Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGIC-101: Glycyrrhizin and Entecavir for Chronic Hepatitis B
NCT03349008Phase 4Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Nov 2017
- Primary completion
- Dec 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 4 trial of Magnesium isoglycyrrhizinate, glycyrrhizin in Chronic Hepatitis B (CHB), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
Magnesium isoglycyrrhizinateglycyrrhizin
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03349008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349008.